"A sense of the bigger picture:" A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use. by Meghan DellaCrosse, Mollie Pleet, Emma Morton, Amir Ashtari, Kimberly Sakai, Josh Woolley, Erin Michalak

“…Emerging evidence suggests psilocybin, the psychoactive compound in "magic mushrooms," is a promising treatment for unipolar depression. …”
Get full text

Alternative Options for Complex, Recurrent Pain States Using Cannabinoids, Psilocybin, and Ketamine: A Narrative Review of Clinical Evidence by Amber N. Edinoff, Juliana M. Fort, Christina Singh, Sarah E. Wagner, Jessica R. Rodriguez, Catherine A. Johnson, Elyse M. Cornett, Kevin S. Murnane, Adam M. Kaye, Alan D. Kaye

“…Psilocybin, commonly known as “magic mushrooms”, works at the serotonin receptor, 5-HT_2A. …”
Get full text

Association of Psilocybin Use in Adolescents with Major Depressive Episode by K. Shah, C. Trivedi, D. Kamrai, M. Akbar, W. Tankersley

“… Introduction Psilocybin is a psychedelic drug found in mushrooms, often referred to as magic mushrooms due to its visual and auditory hallucinations effects upon ingestion. …”
Get full text

New Paradigms of Old Psychedelics in Schizophrenia by Danish Mahmood, Sattam K. Alenezi, Md. Jamir Anwar, Faizul Azam, Kamal A. Qureshi, Mariusz Jaremko

“…Psychedelics such as lysergic acid diethylamide (LSD), psilocybin (magic mushrooms), and mescaline exhibit intense effects on the human brain and behaviour. …”
Get full text

Integration and segregation in whole-brain networks: implications for altered states of consciousness by Lord, L

“…</p> <p>The central focus of this Thesis is to investigate the <em>dynamical</em> properties of the integration/segregation balance in functional MRI data collected in two distinct altered states of consciousness: slow-wave sleep, and a psychedelic experience induced by intravenously administering psilocybin; the psychoactive compound in “magic mushrooms”. </p> <p>In Chapter 2, I implement a novel method for identifying highly integrative nodes in human brain networks from the persistent homology of fMRI data, as a complement to standard graph theoretical methods. …”

Acute psilocybin increased cortical activities in rats by Junhong Liu, Yuanyuan Wang, Yuanyuan Wang, Ke Xia, Jinfeng Wu, Danhao Zheng, Aoling Cai, Haitao Yan, Ruibin Su

“…Psilocybin, a naturally occurring hallucinogenic component of magic mushrooms, has significant psychoactive effects in both humans and rodents. …”
Get full text

A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocol by M. I. Husain, D. M. Blumberger, D. J. Castle, S. M. Kloiber, A. Ortiz, J. D. Rosenblat, B. H. Mulsant

“…Psilocybin, the chemical component of “magic mushrooms”, has been administered with psychotherapy in randomized clinical trials (RCTs) showing large and sustained antidepressant effects. …”
Get full text

Chinese Cordyceps: Bioactive Components, Antitumor Effects and Underlying Mechanism—A Review by Yan Liu, Zhi-Jian Guo, Xuan-Wei Zhou

“…In conclusion, Chinese Cordyceps, one type of magic mushroom, can be potentially developed as immunomodulator and anticancer therapeutic agents.…”
Get full text

A Review of Aeruginascin and Potential Entourage Effect in Hallucinogenic Mushrooms by P. Chue, A. Andreiev, E. Bucuci, C. Els, J. Chue

“… Introduction The 5-HT2A agonist classic psychedelic, psilocybin (O-phosphoryl-4-hydroxy-N,N-dimethyltryptamine) is a tryptophan, indole-based alkaloid present in up to 2% of certain hallucinogenic “magic” mushroom species; typically Psilocybe azurescens, semilanceata, and cyanescens,. …”
Get full text